Status:
COMPLETED
SMART Effectiveness Trial
Lead Sponsor:
Karen Derefinko, PhD
Collaborating Sponsors:
University of Memphis
University of New Mexico
Conditions:
Opioid-use Disorder
Opioid Dependence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The current study piloted two psychosocial interventions developed to increase buprenorphine-naloxone adherence in individuals with opioid use disorder (OUD). Participants were randomized to receive e...
Detailed Description
We engaged with referred OUD patients at the time of their initial visit to the clinic. Interested patients were informed about the study in a private room, and if eligible, were consented and randomi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Present for an intake appointment at study site for treatment of opioid use disorder.
- Eligible for receipt of buprenorphine-naloxone treatment (e.g. Suboxone, Bunavil, Zubsolv) as determined by clinic physicians
- 18 years or older
- Willing to be randomized to one of the two intervention arms
- Ability to comprehend consent and intervention materials (approximately 8th-grade level).
Exclusion
Key Trial Info
Start Date :
August 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 29 2021
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04464421
Start Date
August 17 2020
End Date
August 29 2021
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Tennessee Health Science Center
Memphis, Tennessee, United States, 38163